Document is current
Any future updates will be listed below
-
Authors
Retnakaran, Ravi https://orcid.org/0000-0003-1989-027X
Bu, Dawei
Pu, Jiajie
Connelly, Philip W.
Hanley, Anthony J.
Zhang, Ningyan
An, Zhiqiang
Zinman, Bernard
Scherer, Philipp E.
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research (PJ9-192251)
Cancer Prevention and Research Institute of Texas (RP190561)
Welch Foundation (AU-0042-20030616)
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 19 August 2025
First Online: 29 September 2025
Declarations
:
: The study was approved by the Mount Sinai Hospital Research Ethics Board and all participants provided written informed consent.
: PS, ZA, and NZ were inventors of patent applications filed by the University of Texas System covering anti-endotrophin antibodies and their uses. RR, DB, JP, PWC, AJH and BZ have no conflicts of interest to declare.
